Latest News

  • RESEARCH

    27 Feb 2026

    Can Big Data Crack the Brain’s Toughest Diseases?

  • MARKET TRENDS

    19 Feb 2026

    AI Multi-Omics Meets Market Reality Check

  • RESEARCH

    13 Feb 2026

    AI and Multi-Omics Join Forces to Rethink Drug Discovery

  • INNOVATION

    11 Feb 2026

    NVIDIA Pushes AI Into the Heart of Drug Discovery

Takeda Turns to AI to Reshape Early Drug Discovery

Researchers in a pharmaceutical lab working with automated drug discovery equipment

INVESTMENT

9 Feb 2026

Milestone-based deal with lambic reflects cautious bet on artificial intelligence in pharma research

Nabla Bio office with researchers working on AI driven biologics discovery

INSIGHTS

15 Oct 2025

Inside the AI Rush Reshaping US Biotech

Nabla Bio and Takeda expand their second AI biologics deal as momentum grows and biotech firms rush to modernize discovery

Cancer cells illustration representing AI driven oncology research and targeting

INVESTMENT

19 May 2025

New Funding Pushes AI to the Heart of Oncology

Pathos AI’s major 2025 financing and strategic partnerships signal a faster, data driven shift in oncology development

Tempus headquarters reception representing AI driven cancer research partnership

PARTNERSHIPS

15 May 2025

Data Rich Alliance Points to Future Cancer Wins

Tempus and Boehringer partner to apply AI and multimodal patient data to speed future cancer breakthroughs

Digital DNA helix representing AI driven genomics and data analysis

MARKET TRENDS

16 Apr 2025

Inside the High-Stakes AI Genome Race

Illumina, AstraZeneca, and NVIDIA push AI genomics as pharma shifts toward faster, data-led R&D

Pfizer research facility exterior supporting pharmaceutical research and development

PARTNERSHIPS

7 Feb 2025

Can Data4Cure Give Pfizer an Early Discovery Edge?

Pfizer and Data4Cure advance a multi-year AI effort to boost data integration and accelerate target and biomarker discovery

Schrödinger headquarters reception highlighting AI driven drug discovery company branding

REGULATORY

1 Feb 2025

FDA’s AI Rules Reset Drug Data Standards

FDA’s January 2025 AI draft guidance raises transparency and rigor for models used in regulatory decisions, reshaping development strategi...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.